Key result
Epstein-Barr virus linked to fatal dilated cardiomyopathy with 12% LVEF in an immunocompetent male.
Why the study?
Epstein-Barr virus rarely causes myocarditis, which can progress to dilated cardiomyopathy and acute congestive heart failure with multivalvular regurgitation, but early diagnosis and treatment importance is underemphasized.
Case Report (n=1)
No
This case highlights the importance of early diagnosis and treatment of Epstein-Barr virus myocarditis to prevent progression to dilated cardiomyopathy, heart failure, and mortality.
No takes yet. Share an insight, caveat, or question.
Alerts to EBV in fulminant DCM; leaves open whether antivirals improve survival in immunocompetent patients.
Aknouk et al. (2022) conducted a case report in Epstein-Barr Virus Myocarditis (n=1). Epstein-Barr virus infection was evaluated on Clinical outcome (mortality). Epstein-Barr virus infection in a 20-year-old immunocompetent male led to severe dilated cardiomyopathy with an ejection fraction of 12%, cardiogenic shock, and ultimately death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: